A different approach to decongestion for Acute
Decompensated Heart Failure
WhiteSwell is a patient-focused company dedicated to the treatment of acute decompensated heart failure (ADHF) by supporting the body’s lymphatic system during decongestion.
Leg swelling and difficulty breathing in acute decompensated heart failure (ADHF) are common symptoms that indicate excess fluid in the tissues and organs. Current therapy targets vascular congestion but does not directly target tissue and organ congestion. Even after intravenous diuretic therapy, residual congestion can persist, contributing to poor outcomes. 1, 2, 3
A critical link is the ability of the lymphatic system to remove fluid from the tissue and organs to maintain fluid balance. Lymphatic vessels throughout the body drain and filter 8 liters of fluid per day out of interstitial tissues to the vascular system, where it can be removed with diuretic therapy. In ADHF, the lymphatic system is overwhelmed and cannot effectively drain fluid, causing edema. 4, 5, 6
During ADHF, venous pressure increases, slowing or stopping the drainage of fluid out of the tissues via the lymphatic system’s major highway, the thoracic duct. WhiteSwell engineered the eLym™ System to create a low-pressure zone at the thoracic duct outlet to reduce resistance to lymphatic drainage.7
Curious? Find out more about tissue congestion, the lymphatics and our innovative technology.
A first principles approach is fundamental to rethinking ADHF treatment. Explore opportunities to join our team.
We are a strong team of creative individuals dedicated to improving the treatment of acute decompensated heart failure.
Parkmore Business Park West
Parkmore, Galway, H91 PTT8
Ireland